Merck Receivables 2010-2024 | MRK

Merck receivables for the quarter ending September 30, 2024 were $11.381B, a 9.5% increase year-over-year.

  • Merck receivables for 2023 were $10.349B, a 9.51% increase from 2022.
  • Merck receivables for 2022 were $9.45B, a 2.38% increase from 2021.
  • Merck receivables for 2021 were $9.23B, a 35.68% increase from 2020.

Merck Receivables 2010-2024 | MRK

  • Merck receivables for 2023 were $10.349B, a 9.51% increase from 2022.
  • Merck receivables for 2022 were $9.45B, a 2.38% increase from 2021.
  • Merck receivables for 2021 were $9.23B, a 35.68% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B